IRIS
BABUDIERI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.657
AS - Asia 7.843
EU - Europa 4.708
SA - Sud America 4.362
Continente sconosciuto - Info sul continente non disponibili 553
AF - Africa 303
OC - Oceania 26
AN - Antartide 1
Totale 31.453
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.314
BR - Brasile 3.905
SG - Singapore 3.256
CN - Cina 2.222
UA - Ucraina 1.285
DE - Germania 755
HK - Hong Kong 740
IT - Italia 696
VN - Vietnam 557
FR - Francia 449
SE - Svezia 435
FI - Finlandia 304
GB - Regno Unito 251
AR - Argentina 142
CA - Canada 137
IN - India 133
TR - Turchia 132
BD - Bangladesh 125
MX - Messico 109
RU - Federazione Russa 103
IQ - Iraq 102
ZA - Sudafrica 88
EC - Ecuador 84
JP - Giappone 64
MA - Marocco 62
VE - Venezuela 62
CZ - Repubblica Ceca 61
UZ - Uzbekistan 56
PK - Pakistan 54
PL - Polonia 53
AE - Emirati Arabi Uniti 52
ES - Italia 51
CO - Colombia 47
NL - Olanda 46
BE - Belgio 40
PY - Paraguay 40
AT - Austria 37
KE - Kenya 37
ID - Indonesia 33
NP - Nepal 29
KR - Corea 27
TN - Tunisia 27
AZ - Azerbaigian 26
AU - Australia 25
JO - Giordania 24
PE - Perù 24
UY - Uruguay 24
JM - Giamaica 23
RO - Romania 23
CL - Cile 22
LB - Libano 22
DZ - Algeria 21
DO - Repubblica Dominicana 20
PH - Filippine 20
SA - Arabia Saudita 20
IL - Israele 19
KZ - Kazakistan 18
EG - Egitto 17
LT - Lituania 17
PS - Palestinian Territory 16
KG - Kirghizistan 15
IR - Iran 14
OM - Oman 14
BG - Bulgaria 13
AL - Albania 12
HN - Honduras 12
RS - Serbia 12
EU - Europa 10
HU - Ungheria 10
PA - Panama 9
SN - Senegal 9
BO - Bolivia 8
CH - Svizzera 8
CR - Costa Rica 8
KW - Kuwait 8
MY - Malesia 8
BY - Bielorussia 7
IE - Irlanda 7
XK - ???statistics.table.value.countryCode.XK??? 7
ET - Etiopia 6
MK - Macedonia 6
NG - Nigeria 6
AO - Angola 5
BN - Brunei Darussalam 5
GT - Guatemala 5
NI - Nicaragua 5
QA - Qatar 5
SV - El Salvador 5
AM - Armenia 4
GE - Georgia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
CI - Costa d'Avorio 3
DK - Danimarca 3
GY - Guiana 3
LU - Lussemburgo 3
LY - Libia 3
MD - Moldavia 3
Totale 30.862
Salva come PNG Salva come JPEG
Città #
Dallas 4.078
Singapore 1.748
Chandler 1.432
San Jose 1.107
Jacksonville 738
Hong Kong 728
Ashburn 657
Beijing 470
Princeton 467
Council Bluffs 392
Columbus 322
Nanjing 307
New York 304
Dearborn 286
São Paulo 268
Lauterbourg 242
Munich 193
Ho Chi Minh City 191
Wilmington 191
Los Angeles 175
Sassari 158
Shanghai 158
Santa Clara 151
Boardman 147
Hanoi 147
Ann Arbor 130
Rio de Janeiro 129
Nanchang 126
Helsinki 114
Belo Horizonte 102
Shenyang 101
Brasília 86
Woodbridge 81
Tianjin 76
Hebei 66
Changsha 60
Curitiba 58
Tokyo 58
Rome 57
Brno 56
Porto Alegre 54
Campinas 52
Nuremberg 49
Guarulhos 48
Orem 48
Warsaw 47
Frankfurt am Main 46
Salvador 46
Tashkent 46
Johannesburg 45
Toronto 45
Denver 44
Montreal 43
San Francisco 42
Atlanta 41
Goiânia 41
The Dalles 40
Brooklyn 39
Brussels 39
Buffalo 39
Jiaxing 39
Cagliari 37
Chennai 37
Guangzhou 36
Ningbo 36
Zhengzhou 36
Jinan 35
Ribeirão Preto 34
Kunming 33
Nairobi 33
Chicago 32
London 32
Andover 31
Guayaquil 31
Norwalk 31
Baghdad 30
Dhaka 30
São José dos Campos 30
Fortaleza 29
Houston 28
Milan 27
Seoul 27
Sorocaba 27
Santo André 26
Stockholm 26
Asunción 25
Istanbul 25
Phoenix 25
Ankara 24
Baku 24
Hangzhou 24
Izmir 23
Poplar 23
Turku 23
Amman 22
Quito 22
Taizhou 22
Campo Grande 21
Da Nang 21
Florianópolis 21
Totale 18.389
Salva come PNG Salva come JPEG
Nome #
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 284
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 280
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 268
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 221
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 216
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 214
A case of vasculitis-like skin eruption associated with COVID-19 212
Anaerobic bacteria and bacterial infections: perspectives on treatment and resistence in Italy 205
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 204
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 200
Associazione tra Tubercolosi ed infezione da HIV: programma per uno studio multicentrico 199
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 198
Blood born viral infections, sexually transmitted diseases and latent tuberculosis in italian prisons: a preliminary report of a large multicenter study 193
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 189
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 185
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 184
Application of a miniaturized system to the study of the intestinal microflora 181
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 177
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 176
Beta2-microglobulin and Neopterin: predictive markers of AIDS in HIV infection 175
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 175
An outbreak of Q fever in a prison in Italy 174
Evaluation of EZH2 expression in hepatitis B patients 174
A young woman with hepatitis after a sore throat 173
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 173
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 169
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA 168
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 167
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 163
Association of Tuberculosis risk with the degree of tubercolin reaction in HIV-infected patients 163
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 162
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 162
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 162
Dental care and HIV-infected individuals: are they equally treated? 162
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 160
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 159
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 158
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 156
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 154
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 152
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 152
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 152
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 149
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 147
Identification of HIV patients with active pulmonary tuberculosis using urine based polymerase chain reaction assay 144
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 144
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 144
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 143
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 142
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? 142
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 141
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 140
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 140
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 140
An Outbreak of Q fever in a prison in Italy 138
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 137
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 136
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 135
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 135
Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons 135
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 134
Travel-Related Typhoid Fever: Narrative Review of the Scientific Literature 134
Relazione tra antigenemia ed anticorpi nell'evoluzione dell'infezione da HIV 134
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 133
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 132
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 131
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries 131
Produzione di linee cellulari ibride per l'isolamento di virus linfotropi 131
Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: Role of neutropenia and of interferon pegylation 131
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 130
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 129
Clostridi elicoidali: nuovi patogeni intestinali? Comparazione tra un ceppo umano e ceppi di provenienza animale 128
L'attività di Imipenem contro i microrganismi anaerobi: studio policentrico su ceppi isolati da infezioni umane e confronto in vitro con altri antibiotici 128
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 127
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 127
Feasibility and efficacy of eight weeks Glecaprevir/Pibrentasvir to treat incarcerated viremic HCV patients: a case-control study 127
Infectious diseases screening approach among refugees: Results from a single-center study 127
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 126
Trasmissione eterosessuale dell'infezione da HIV1 nella provincia di Sassari 126
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 125
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 125
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 124
Characterization of resistance profiles in HCV 2-3-4 DAA-naive and DAA-experienced infected patients in Italy 124
Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled study 124
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL) 123
Tache Noire in a Patient with Acute Q Fever 123
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 123
Enterococcal infections of the respiratory tract in HIV patients 122
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 122
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 122
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 122
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 122
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 121
HIV related aneurisms 121
Flora batterica intestinale ed organismo ospite; aspetti attuali di fisiopatologia 120
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 120
HNK1 perifereal blood lymphocytes in HIV infected patients 120
Eritema cronico migrante 120
Spirochaeta, genere 120
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study 119
Totale 15.311
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.151
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022943 0 14 7 13 10 15 41 79 89 62 134 479
2022/20232.754 278 161 68 455 299 447 23 321 466 29 113 94
2023/2024904 152 60 24 25 238 117 15 42 1 5 64 161
2024/20258.234 131 90 490 200 315 265 748 1.550 2.729 1.122 342 252
2025/202612.090 496 3.087 1.815 1.625 1.171 664 1.700 324 445 480 199 84
2026/2027935 235 700 0 0 0 0 0 0 0 0 0 0
Totale 31.453